111.00
+1.04
+(0.95%)
At close: April 17 at 6:52:47 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 18 | 18 |
| Avg. Estimate | 2.04B | 2.19B | 8.74B | 9.21B |
| Low Estimate | 2.02B | 2.15B | 8.56B | 8.98B |
| High Estimate | 2.07B | 2.25B | 8.89B | 9.41B |
| Year Ago Sales | 2.03B | 2.17B | 8.56B | 8.74B |
| Sales Growth (year/est) | 0.43% | 1.14% | 2.09% | 5.34% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0M29.L | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Maintains | Stifel: Buy to Buy | 4/16/2025 |
| Maintains | Citigroup: Buy to Buy | 4/14/2025 |
| Maintains | Baird: Outperform to Outperform | 2/5/2025 |
| Maintains | Stifel: Buy to Buy | 1/24/2025 |
| Maintains | Citigroup: Buy to Buy | 1/13/2025 |
| Downgrade | Wolfe Research: Outperform to Peer Perform | 12/12/2024 |